AstraZeneca to Buy Icosavax for Up to $1.1 Bln -- Update

By Ian Walker AstraZeneca said it would buy U.S.-based clinical-stage biopharmaceutical company Icosavax for up to $1.1 billion in a deal that expands its...

Related Keywords

Iskra Reic ,Ian Walker ,Astrazeneca ,Immune Therapies ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Vaccines ,Healthcare Life Sciences ,Biopharmaceuticals ,Specialized Drugs Medications ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Acquisitions Mergers ,Corporate Actions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Icosavax ,Icvx ,Azn Ln ,Uk Azn ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,